Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about ANVS

Recent news which mentions ANVS

< Previous 1 2 3 Next >
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
Tickers ANVS
Tags Biotech ANVS Movers & Shakers
From Benzinga
Publication Of Peer-Reviewed Study In Journal Of The Alzheimer's Association Could Mark A Significant Step For Longeveron
Tickers ANVS LGVN LLY TECH
Tags Benzinga FDA LLY
From Benzinga
Dear AMC Stock Fans, Mark Your Calendars for Aug. 4
Tickers AMC ANVS GME VIVO
Tags VIVO ANVS Today's Market
From InvestorPlace
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Tickers ANVS GME
Tags Market News ANVS Today's Market
From InvestorPlace
FDA Gives Green Signal To Annovis Bio's Parkinson's Trial With Buntanetap
Tickers ANVS
Tags Movers News Briefs
From Benzinga
Annovis Bio Gets FDA Nod For Late-Stage Parkinson Disease Study Amendments
Tickers ANVS
Tags Clinical Trial Amendments Market News Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Tickers ACRX ALNA ANVS AVRO
Tags Pre/Market Outlook Movers THMO
From Benzinga
83 Biggest Movers From Yesterday
Tickers ACLX ADTH AERC AMLX
Tags DDL REKR AUVI
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
Tickers ACLX ACRX AERC ANVS
Tags TLSA Market News AERC
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
Tickers ACCD AJG ANVS ARTA
Tags CMA SLCA TSVT
From Benzinga
The Daily Biotech Pulse: FDA Approves Bristol Myers' Oral Heart Disease Drug, European Approval For Merck's Keytruda, Genocea Restructures, Zymeworks' Takeover Bid
Tickers ABBV ALDX ANVS AZN
Tags Earnings ALDX PRQR
From Benzinga
FDA Guides Annovis Bio For Two Phase 3 Buntanetap Trial In Parkinson's Disease
Tickers ANVS
Tags Parkinson’s Disease Market News Trading Ideas
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Tickers ABEO ALRN ANVS ATHE
Tags BZI/TFM EVOK ATHE
From Benzinga
Annovis Bio on Its Positive Results in Alzheimer's and Parkinson's Clinical Trials
Tickers ANVS BIIB
Tags Benzinga Market News Markets
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Tickers ACRX ANVS BLPH CWBR
Tags Market News TRVI CYAD
From Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
Tickers ADPT AFIB ANVS ATHX
Tags ADPT Earnings NEXI
From Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
Tickers ACHV ACIU AEMD AGEN
Tags FDA OMER CAPR
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
Tickers ABUS ACAD ACIU ADAP
Tags BHVN Benzinga Penny Stocks
From Benzinga
92 Biggest Movers From Friday
Tickers AAOI ABNB ADGI ADTX
Tags REV FLR RANI
From Benzinga
44 Biggest Movers From Yesterday
Tickers ALF AMN ANVS AZYO
Tags Movers VIOT JSPR
From Benzinga
3 Stocks Insiders Are Buying
Tickers ANVS LSCC LTH
Tags Market News LSCC Markets
From Benzinga
EXCLUSIVE: Annovis Bio's Parkinson's Candidate Improves Speed, Motor Function Vs Placebo
Tickers ANVS
Tags Briefs News General
From Benzinga
Here's How You Handle a Volatile Stock Like Cassava Sciences
Tickers ANVS INMB SAVA
Tags INMB SAVA Market News
From Motley Fool
Insiders Like Cassava Sciences, Which Might Be Good News
Tickers ANVS SAVA
Tags ANVS SAVA Market News
From InvestorPlace
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Tickers ABBV ALZN AMRX ANVS
Tags Earnings BLFS BCRX
From Benzinga
Better Biotech Stock: Cassava Sciences vs. Annovis Bio
Tickers ANVS BIIB SAVA
Tags ANVS Market News SAVA
From Motley Fool
Tread Carefully Before Pulling the Trigger on Cassava Sciences
Tickers ANVS SAVA
Tags NASDAQ:SAVA,NYSEAMERICAN:ANVS Hot Stocks SAVA
From InvestorPlace
Why Might Cassava Succeed With Its Alzheimer's Drug, When So Many Have Failed?
Tickers ANVS BIIB SAVA
Tags ANVS SAVA Market News
From Motley Fool
Why Is Biogen Pursuing a New Direction in Alzheimer's Research?
Tickers ANVS AVXL BIIB SAVA
Tags ANVS SAVA Market News
From Motley Fool
Use Weakness in these 3 Alzheimer’s Disease Stocks as Opportunity
Tickers ANVS AVXL SAVA
Tags Hot Stocks AVXL ANVS
From InvestorPlace
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.